Cross-sectional study of health impairment related to post COVID-19 condition among participants of a large population-based cohort in Germany
Sophie Diexer(Medical University of Vienna), Rafael Mikolajczyk(Martin Luther University Halle-Wittenberg), Claudia Meinke‐Franze(Universitätsmedizin Greifswald), Sabine Gabrysch(Heidelberg University), Thomas Keil(Zurich University of Applied Sciences in Business Administration), Julia Fricke(Charité - Universitätsmedizin Berlin), Carolina Judith Klett-Tammen(Helmholtz Centre for Infection Research), Ilais Moreno Velásquez(Max Delbrück Center), Jonas Frost(Luther University), Rudolf Kaaks(German Cancer Research Center), Michael F. Leitzmann(University of Regensburg), Tamara Schikowski(Bielefeld University), Laura R Pfrommer(Martin Luther University Halle-Wittenberg), Börge Schmidt(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Volker Harth(Universität Hamburg), Hajo Zeeb(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Benedikt Lampl(OTH Regensburg), Bianca Klee(Luther University), Nadia Obi(Universität Hamburg), Oliver Purschke(German Centre for Integrative Biodiversity Research), Karin B. Michels(University Medical Center Freiburg), Hermann Brenner(Universidad de Granada), Lilian Krist(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), André Karch(University of Münster), Marvin N. Wright(Hochschule Bremen), Wolfgang Lieb(Hochschule für Angewandte Wissenschaften Kiel), Nicole Rübsamen(University of Münster), Henry Völzke(Universitätsmedizin Greifswald), Jana-Kristin Heise(Helmholtz Centre for Infection Research), Annette Peters(Helmholtz Munich), Tobias Pischon(Max Delbrück Center), Peter Ahnert(Leipzig University), Sigrid Thierry(University of Augsburg), Till Baernighausen(Harvard University), Karin Halina Greiser(Heidelberg University)
Cited by 1
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k